Genetics consortiums can offer views facilitating best practice in Alzheimer’s disease

Por Lovestone, Simon
Publicado em 1998

Fleshing out the amyloid cascade hypothesis: the molecular biology of Alzheimer's disease

Por Lovestone, Simon
Publicado em 2000

Blood biomarkers for Alzheimer’s disease

Por Lovestone, Simon
Publicado no Genome Med (2014)

The European medical information framework: A novel ecosystem for sharing healthcare data across Europe

Por Lovestone, Simon
Publicado no Learn Health Syst (2019)

Blood-based biomarkers of Alzheimer’s disease: challenging but feasible

Por Thambisetty, Madhav, Lovestone, Simon
Publicado em 2010

Management of dementia /

Por Lovestone, Simon, Gauthier, Serge
Publicado em c200

Advanced glycation end products, dementia, and diabetes

Por Lovestone, Simon, Smith, Ulf
Publicado em 2014

The GSK3 hypothesis of Alzheimer's disease

Por Hooper, Claudie, Killick, Richard, Lovestone, Simon
Publicado em 2008

Determining the Molecular Pathways Underlying the Protective Effect of Non-Steroidal Anti-Inflammatory Drugs for Alzheimer's Disease: A Bioinformatics Approach

Por Nevado-Holgado, Alejo J, Lovestone, Simon
Publicado no Comput Struct Biotechnol J (2016)

Alzheimer’s Disease, Diagnosis and the Need for Biomarkers

Por Hooper, Claudie, Lovestone, Simon, Sainz-Fuertes, Ricardo
Publicado em 2008

Blood-Based Proteomic Biomarkers of Alzheimer’s Disease Pathology

Por Baird, Alison L., Westwood, Sarah, Lovestone, Simon
Publicado no Front Neurol (2015)

The Notch-1 intracellular domain is found in sub-nuclear bodies in SH-SY5Y neuroblastomas and in primary cortical neurons

Por Hooper, Claudie, Chapple, J. Paul, Lovestone, Simon, Killick, Richard
Publicado em 2007

The Importance of Tau Phosphorylation for Neurodegenerative Diseases

Por Noble, Wendy, Hanger, Diane P., Miller, Christopher C. J., Lovestone, Simon
Publicado em 2013

Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer’s disease

Por Winchester, Laura M., Powell, John, Lovestone, Simon, Nevado-Holgado, Alejo J.
Publicado no Genome Med (2018)

Comprehensive Real-World Assessment of Marketed Medications to Guide Parkinson’s Drug Discovery

Por Cepeda, M. Soledad, Kern, David M., Seabrook, Guy R., Lovestone, Simon
Publicado no Clin Drug Investig (2019)

Aiding the discovery of new treatments for dementia by uncovering unknown benefits of existing medications

Por Kern, David M., Cepeda, M. Soledad, Lovestone, Simon, Seabrook, Guy R.
Publicado no Alzheimers Dement (N Y) (2019)

p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells

Por Hooper, Claudie, Meimaridou, Eirini, Tavassoli, Mahvash, Melino, Gerry, Lovestone, Simon, Killick, Richard
Publicado em 2007

Ageing Increases Vulnerability to Aβ42 Toxicity in Drosophila

Por Rogers, Iain, Kerr, Fiona, Martinez, Pedro, Hardy, John, Lovestone, Simon, Partridge, Linda
Publicado em 2012

Commonly prescribed drugs associate with cognitive function: a cross-sectional study in UK Biobank

Por Nevado-Holgado, Alejo J, Kim, Chi-Hun, Winchester, Laura, Gallacher, John, Lovestone, Simon
Publicado no BMJ Open (2016)

Effects of freezer storage time on levels of complement biomarkers

Por Morgan, Angharad R., O’Hagan, Caroline, Touchard, Samuel, Lovestone, Simon, Paul Morgan, B.
Publicado no BMC Res Notes (2017)